Liver fluke treatment tested in 300 patients
NCT ID NCT04230148
Summary
This study is checking how safe and effective the drug Egaten is for treating fascioliasis, a parasitic liver infection. About 300 adults and children aged 6 and older with the infection will take two doses of the medicine 12 hours apart. Researchers will monitor patients for side effects and track whether their symptoms and infection clear up over 90 days.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FASCIOLIASIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Novartis Investigative Site
Medellín, Antioquia, 050010, Colombia
-
Novartis Investigative Site
Alexandria, 21131, Egypt
-
Novartis Investigative Site
Cairo, 11617, Egypt
-
Novartis Investigative Site
San Martín de Porres, Lima region, 31, Peru
-
Novartis Investigative Site
Cusco, 84, Peru
-
Novartis Investigative Site
Istanbul, Fatih, 34093, Turkey (Türkiye)
-
Novartis Investigative Site
Gaziantep, Sehitkamil, 27310, Turkey (Türkiye)
-
Novartis Investigative Site
Sur, 21280, Turkey (Türkiye)
-
Novartis Investigative Site
Van, 65080, Turkey (Türkiye)
-
Novartis Investigative Site
Qui Nhon, Binh Dinh, 590000, Vietnam
Conditions
Explore the condition pages connected to this study.